Canada markets open in 21 minutes

Uniti Group Inc. (UNIT)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
11.06-0.10 (-0.85%)
At close: 4:00PM EDT

11.06 0.00 (0.00%)
Pre-Market: 8:18AM EDT

Full screen
Trade prices are not sourced from all markets
Previous Close11.16
Open11.01
Bid10.77 x 2900
Ask11.29 x 3000
Day's Range10.85 - 11.21
52 Week Range6.58 - 13.40
Volume2,307,380
Avg. Volume1,974,868
Market Cap2.584B
Beta (5Y Monthly)0.95
PE Ratio (TTM)N/A
EPS (TTM)-3.47
Earnings DateMay 06, 2021
Forward Dividend & Yield0.60 (5.42%)
Ex-Dividend DateJun. 17, 2021
1y Target Est12.33
  • Uniti Group Inc. Declares $0.15 Per Share Quarterly Dividend
    GlobeNewswire

    Uniti Group Inc. Declares $0.15 Per Share Quarterly Dividend

    LITTLE ROCK, Ark., May 04, 2021 (GLOBE NEWSWIRE) -- Uniti Group Inc. (“Uniti”) (Nasdaq: UNIT) announced today that its Board of Directors declared a quarterly cash dividend of $0.15 per share, payable on July 2, 2021 to stockholders of record on June 18, 2021. ABOUT UNITI Uniti, an internally managed real estate investment trust, is engaged in the acquisition and construction of mission critical communications infrastructure, and is a leading provider of wireless infrastructure solutions for the communications industry. As of December 31, 2020, Uniti owns over 123,000 fiber route miles, approximately 6.9 million fiber strand miles, and other communications real estate throughout the United States. Additional information about Uniti can be found on its website at www.uniti.com. INVESTOR AND MEDIA CONTACTS: Mark A. Wallace, 501-850-0866Executive Vice President, Chief Financial Officer & Treasurermark.wallace@uniti.com Bill DiTullio, 501-850-0872Vice President, Finance and Investor Relationsbill.ditullio@uniti.com

  • Uniti Group Inc. To Report First Quarter 2021 Financial Results and Host Conference Call
    GlobeNewswire

    Uniti Group Inc. To Report First Quarter 2021 Financial Results and Host Conference Call

    LITTLE ROCK, Ark., April 15, 2021 (GLOBE NEWSWIRE) -- Uniti Group Inc. (“Uniti”) (Nasdaq: UNIT) announced today that it will report its first quarter 2021 financial results after the close of trading on the Nasdaq Stock Exchange on May 6, 2021. A conference call to discuss those earnings will be held the same day at 4:15 PM Eastern Time. The dial-in number for the conference call is (800) 708-4540 (or (847) 619-6397 for international callers) and the conference ID is 50149687. The call will also be webcast live and can be accessed at the Company’s website at www.uniti.com. A replay of the call will be available on the Company’s website or by telephone beginning on May 6, 2021 at approximately 8:00 PM Eastern Time. To access the telephone replay, which will be available for 14 days, please dial (855) 859-2056 and enter the conference ID number 50149687. ABOUT UNITI Uniti, an internally managed real estate investment trust, is engaged in the acquisition and construction of mission critical communications infrastructure, and is a leading provider of wireless infrastructure solutions for the communications industry. As of December 31, 2020, Uniti owns over 123,000 fiber route miles, approximately 6.9 million fiber strand miles, and other communications real estate throughout the United States. Additional information about Uniti can be found on its website at www.uniti.com. INVESTOR and MEDIA CONTACTS: Mark A. Wallace, 501-850-0866Executive Vice President, Chief Financial Officer & Treasurermark.wallace@uniti.com Bill DiTullio, 501-850-0872Vice President, Finance & Investor Relationsbill.ditullio@uniti.com

  • Bragar Eagel & Squire is Investigating Certain Officers and Directors of Uniti Group, Surgalign Holdings, Tyson Foods, and Tricida on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
    GlobeNewswire

    Bragar Eagel & Squire is Investigating Certain Officers and Directors of Uniti Group, Surgalign Holdings, Tyson Foods, and Tricida on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

    NEW YORK, April 09, 2021 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating certain officers and directors of Uniti Group, Inc. (NASDAQ: UNIT), Surgalign Holdings, Inc. (f/k/a RTI Surgical Holdings, Inc.) (Nasdaq: SRGA), Tyson Foods (NYSE: TSN), and Tricida, Inc. (NASDAQ: TCDA) on behalf of long-term stockholders. More information about each potential case can be found at the link provided. Uniti Group, Inc. (NASDAQ: UNIT) Bragar Eagel & Squire is is investigating certain officers and directors of Uniti Group, Inc. following news that the Shareholder Class Action Against Uniti Group has survived the motions to dismiss in the pending securities class action and may face damages. The complaint alleges that Uniti made materially false and/or misleading statements and/or failed to disclose that: (i) Uniti’s financial results were not sustainable because its customer Windstream had defaulted on its unsecured notes; and (ii) as a result of the foregoing, defendants’ statements about Uniti’s business, operations, and prospects, were false and misleading and/or lacked a reasonable basis. To learn more about our investigation into Uniti Group go to: https://bespc.com/cases/UNIT Surgalign Holdings, Inc. (f/k/a RTI Surgical Holdings, Inc.) Bragar Eagel & Squire is is investigating certain officers and directors of Surgalign Holdings, Inc. (f/k/a RTI Surgical Holdings, Inc.), following news that the Shareholder Class Action Against Surgalign has survived the motions to dismiss in the pending securities class action and may face damages. According to the lawsuit, defendants throughout the class period made false and/or misleading statements and/or failed to disclose that: (1) the Company inappropriately recognized revenues with respect to certain contractual arrangements, including other equipment manufacturer customers; (2) the Company’s internal controls over financial reporting were not effective; (3) as a result, the Company would be forced to delay the filing of its Form 10-K for fiscal year ended December 31, 2019; and (4) as a result, defendants' statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times. To learn more about our investigation into Surgalign go to: https://bespc.com/cases/SRGA Tyson Foods, Inc. (NYSE: TSN) Bragar Eagel & Squire is investigating certain officers and directors of Tyson Foods, Inc. following a class action complaint that was filled against Tyson on February 2, 2021. The complaint alleges that defendants throughout the class period made false and/or misleading statements and/or failed to disclose that: (1) Tyson knew, or should have known, that the highly contagious coronavirus was spreading throughout the globe; (2) Tyson did not in fact have sufficient safety protocols to protect its employees in its facilities; (3) as a result, Tyson employees contracted and spread the coronavirus within the facilities; (4) as a result of the foregoing, Tyson would face negative impact to its production, including complete shutdowns of certain facilities; (5) due to the failure to protect its employees, Tyson would suffer financial harm related to its lowered production; and (6) as a result, defendants’ public statements were materially false and/or misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages. For more information on the Tyson Foods investigation go to: https://bespc.com/cases/TSN Tricida, Inc. (NASDAQ: TCDA) Bragar Eagel & Squire is investigating certain officers and directors of Tricida, Inc. following a class action complaint that was filled against Tricida on January 6, 2021. The complaint alleges that throughout the class period defendants made materially false and misleading statements, and failed to disclose material adverse facts about the Company’s business, operational, and compliance policies. Specifically, defendants made false and/or misleading statements and failed to disclose to investors that: (i) Tricida’s NDA for veverimer was materially deficient; (ii) accordingly, it was foreseeably likely that the FDA would not accept the NDA for veverimer; and (iii) as a result, the Company’s public statements were materially false and misleading at all relevant times. For more information on the Tricida investigation go to: https://bespc.com/cases/TCDA About Bragar Eagel & Squire, P.C.:Bragar Eagel & Squire, P.C. is a nationally recognized law firm with offices in New York, California, and South Carolina. The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country. For more information about the firm, please visit www.bespc.com. Attorney advertising. Prior results do not guarantee similar outcomes. Contact Information:Bragar Eagel & Squire, P.C.Brandon Walker, Esq. Melissa Fortunato, Esq.Marion Passmore, Esq.(212) 355-4648investigations@bespc.comwww.bespc.com